GNRH1 and myocardial infarction: Patients receiving GnRH agonists had significantly more non-fatal and fatal cardiovascular events (coronary heart disease, myocardial infarction, sudden cardiac death or life-threatening ventricular arrhythmias) compared to patients without GnRH agonists.